Companies & Industry »Company News
Sun Pharmaceuticals Industries Ltd - Company News

BSE   28 Apr 17 | 04:01 PM

642.55 5.6 (0.88%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 524715
Face Value: 1

NSE   28 Apr 17 | 03:59 PM

641.95 4.95 (0.78%)
Mkt Price (Rs)   Chg Rs (Chg %)
1 Week : Rs 640.05 (0.39%)
1 Month : Rs 698.55 (-8.02%)
1 Year : Rs 802.55 (-19.94%)
change companytradenow

  • 15 Mar 17
    12:38 AM
    India’s largest drugmaker Sun Pharmaceuticals has informed the exchanges the US Food and Drug Administration (FDA) has said it would remove more than three-year-old import sanctions on its Mohali plant.
  • 14 Mar 17
    02:58 PM
    A logo of Sun Pharmaceutical Industries Ltd is pictured at its research and development centre in Mumbai (Photo: Reuters)The US health regulator has proposed to lift the import alert on Sun Pharma's Mohali (Punjab) based manufacturing plant.
    01:59 PM
    Sun Pharmaceutical Industries has moved higher by 7% to Rs 729 on the National Stock Exchange (NSE) after the company said the US health regulator will lift the import alert to permit the supply of products from Mohali facility to the US market.
  • 03 Feb 17
    05:00 AM
    A trial court on Thursday discharged former telecom minister Dayanidhi Maran, his brother Kalanithi Maran and others in the Aircel-Maxis deal cases lodged by the Central Bureau of Investigation (CBI) and Enforcement Directorate (ED).
  • 27 Dec 16
    09:20 AM
    CapsulesThe Sun Pharma stock got some respite last Friday as the company announced plans to acquire branded oncology product Odomzo from Novartis in the US.
  • 26 Dec 16
    04:55 AM
    Close to two years after Dilip Shanghvi-led Sun Pharmaceutical completed the acquisition of Ranbaxy, indications are that the Ranbaxy portfolio’s contribution has grown from 32 per cent to 37 per cent of the combined India sales.
  • 11 Nov 16
    09:50 AM
    Sun Pharmaceutical Industries has rallied 6% to Rs 708 on BSE in early morning trade after the pharma major's consolidated net profit more than doubles to Rs 2,235 crore for the quarter ended September 30, 2016 (Q2FY17).
    06:44 AM
    Strong sales growth in the  key US  market and  product licensing income helped Sun Pharmaceutical Industries double its consolidated net profit in the September quarter, year on year.
  • 28 Oct 16
    03:18 PM
    Shares of select pharmaceutical companies have surged by up to 12% on BSE in intra-day after they reported robust earnings for the quarter ended September 30, 2016 (Q2FY17).
  • 27 Oct 16
    11:57 AM
    Sun Pharmaceutical Industries on Thursday said it has launched generic versions of Daiichi Sankyo medicines, used in treatment of high blood pressure, in the US market.
Widgets Magazine


Company Price Gain (%)
O N G C186.303.76
St Bk of India289.452.66
Maruti Suzuki6,525.502.42
ICICI Bank278.501.62
Asian Paints1,120.501.62
Widgets Magazine

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine